Stay up to date with our latest news and events.
Proteos recently added Mouse alpha-Synuclein Monomer to Generate Pre-formed Fibrils to our online catalog of validated protein reagents, generated in collaboration with the Michael J. Fox Foundation (MJFF), to support Parkinson’s disease (PD) research. Alpha-synuclein products are available for order online at https://www.proteos.com/order.
On this day 15 years ago, Proteos was incorporated and began providing recombinant protein production services to the biopharma industry.
Proteos is rapidly approaching the celebration of 15 years in business. In this first of a two-part blog series, we want to take a moment to reflect on the founding of Proteos. Proteos co-founder, Robert Heinrikson, PhD, graciously provided a historical perspective for our company.
At Proteos, we understand that it is our employees that make our company special. Proteos’ scientific staff has decades of combined experience in the biotechnology and life science industries. As we continue featuring staff profiles on our blog, we are very excited to welcome Joanna Sutton to the Proteos team.
Proteos will be exhibiting at the Protein Engineering Summit (PEGS Boston 2018). Please stop by booth #712 to learn why Proteos is an industry leader in the production of high-quality recombinant proteins and antibodies.
Proteos has been recognized as one of the 2018 “Best Small Businesses,” an awards program presented by Michigan Celebrates Small Business. Proteos will receive the SmartZone Best Small Business of the Year Award for 2018.
At Proteos, we understand that it is our employees that make our company special. Proteos’ scientific staff has decades of combined experience in the biotechnology and life science industries. We feature staff profiles on our blog so that you can learn a bit more about the hard-working individuals responsible for orchestrating your recombinant protein production projects. Our staff profile series continues with Tony Sutter.
Proteos specializes in custom recombinant protein production. Customers can request a customized quotation for protein production services or purchase protein production packages, assay services, and recombinant protein products.
Proteos, Inc. announced on Monday January 29, 2018 that the company would begin the process of restructuring and transitioning to a majority employee-owned corporation.
Proteos is proud to support life science research taking place around the world by supplying high-quality protein and antibody reagents to our valued customers. In just the past 3 months (November 2017 through January 2018), we delivered proteins and antibodies to 28 U.S. and 9 international locations.
